The nation of Zimbabwe has declined a substantial US health deal valued at 367 million US dollars (£272m) over five years due to Washington's request for confidential information.
This rejection became public after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative has since stated that the US was demanding access to genetic material for research and commercial gain but refused to guarantee the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to secure a deal suitable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost openness and accountability.
Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our population should a new health crisis emerge."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks previously established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This system is designed to ensure that when a country contributes its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage continued discussions with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but recommended that negotiations need to persist since a large portion of the country's HIV programmes were funded by foreign aid.
"Where specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
The situation emphasises the continuing challenges between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.